Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/1/2025

Insulin Glargine Dosing and Administration for Elderly Patients

Dosing and Titration

  • The American Diabetes Association recommends administering insulin glargine in the morning rather than at bedtime to reduce nocturnal hypoglycemia risk in elderly patients 1, 2, 3
  • Titrate dose based on fasting finger-stick glucose results over one week, with a target fasting glucose of 90-150 mg/dL (5.0-8.3 mmol/L) 1, 2, 3
  • Increase dose by 2 units if ≥50% of fasting values are above goal, and decrease dose by 2 units if >2 fasting values/week are <80 mg/dL 1, 2, 3

Hypoglycemia Risk Reduction

  • Consider starting with a lower dose (0.1-0.15 units/kg = 7-11 units) if the patient has reduced oral intake, frailty, or multiple comorbidities 4
  • Ensure patient or caregiver can recognize and treat hypoglycemia 5

Individualized Glycemic Targets

  • The A1C target should be adjusted based on the patient's health status, with targets of <7.0-7.5% for healthy elderly, <8.0% for complex/intermediate health, and <8.5% for very complex/poor health 1, 2

Monitoring Requirements

  • Check fasting glucose daily during titration phase 1, 2, 3
  • Assess for hypoglycemia symptoms, especially nocturnal 1, 2
  • Evaluate cognitive and functional status to ensure safe insulin administration 5

Common Pitfalls to Avoid

  • Do not administer insulin glargine at bedtime initially in elderly patients due to increased nocturnal hypoglycemia risk 1, 2, 3
  • Do not use aggressive titration (>2 units/week) in older adults 1, 2, 3